Benign Prostatic Hyperplasia

Latest News

August 5th 2020

Holmium laser advances help propel progress in BPH, urinary stones

Holmium laser lithotripsy with Moses 2.0 is intended to enhance precision and versatility by optimizing laser energy transmission.

August 3rd 2020

PINNACLE trial aims to confirm pilot success with BPH drug-coated balloon catheter

By Jason M. Broderick and Cheryl Guttman Krader, BS, Pharm

July 29th 2020

5-year data sustain water vapor thermal therapy benefit in BPH-related LUTS

By Jason M. Broderick

July 23rd 2020

HoLEP may provide more durable benefit than PVP in patients with BPH

By Cheryl Guttman Krader, BS, Pharm

July 14th 2020

BPH catheter system shows encouraging outcomes in pilot trial

By Cheryl Guttman Krader, BS, Pharm

Latest Videos

Dr. Zorn on new technologies to optimize care for BPH

blur image background of corridor in hospital or clinic image | Image Credit: © whyframeshot - stock.adobe.com

Dr. Friel and Dr. Sterling on patient selection for Aquablation for BPH

Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com

Urologists share their initial experience with BPH treatment Aquablation

Illustration of Benign Prostatic Hyperplasia | Image Credit: © Judith - stock.adobe.com

Dr. Sterling and Dr. Friel discuss Aquablation for BPH

Dr. Wymer on the implications of BPH procedure cost data

Investigators compare costs for surgical treatments of BPH

Dr. McVary in an interview with Urology Times

Dr. McVary discusses early promise with Rezum in large prostates

Study assesses Rezum therapy in large prostates

Kevin C. Zorn, MD, FRCSC, FACS, answers a question during an interview

Dr. Zorn on prostatic artery embolization for BPH

Dr. Elterman on the new wave of BPH stents

CME Content

Video

Medical Crossfire® in Adjunctive Testing: Charting a New Course in Prostate Cancer Risk Assessment

Jason Hafron, MD; Aaron D. Berger, MD; Arpeet Shah, MD

Multimedia

Working Together: Overcoming Barriers to Optimize Outcomes in Patients Treated With Radioligand Therapy Through Multidisciplinary Care

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Nerina McDonald, MSPAS, PA-C; Scott T. Tagawa, MD, MS, FACP, FASCO

Multimedia

BURST CME™ Resource Center: Integrating Novel PSMA-Directed Radioligand Approaches for Diagnosis and Management of Prostate Cancer

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Nerina McDonald, MSPAS, PA-C; Scott T. Tagawa, MD, MS, FACP, FASCO

Multimedia

Radioligand Therapy 101: The Science Behind the Strategy

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Scott T. Tagawa, MD, MS, FACP, FASCO

Multimedia

Ready for Radioligand Therapy? Patient Selection and Sequencing Simplified

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Scott T. Tagawa, MD, MS, FACP, FASCO

Multimedia

Community Practice Connections™: Beyond the Basics— Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies

Jeremie Calais, MD, PhD; Scott T. Tagawa, MD, MS, FACP, FASCO

Video

Enhancing Prostate Cancer Outcomes – The Role of PSMA and Targeted Treatment Strategies

Ana Kiess, MD, PhD; Erin Grady, MD, CCD, FACNM, FSNMMI; Himanshu Nagar, MD, MS; Scott T. Tagawa, MD, MS, FASCO, FACP

More News

Panel expert details changes to AUA BPH guideline

ByJason M. Broderick

July 10th 2020

Steven A. Kaplan, MD, explains the updates in the AUA 2020 guideline on lower urinary tract symptoms secondary to benign prostatic hyperplasia.

Photoselective vaporization of the prostate found safe, durably effective

ByCheryl Guttman Krader, BS, Pharm

June 23rd 2020

Only 1.5% of patients undergo repeat surgical intervention for BPH recurrence.

PROs favor prostatic urethral lift over water vapor ablation for BPH symptoms

ByJason M. Broderick

June 22nd 2020

Patient-reported outcomes showed a superior experience regarding post-procedure BPH symptoms with the UroLift prostatic urethral lift over Rezum tissue ablation with steam injection.

Benign Prostatic Hyperplasia

Latest News

Latest Videos

Dr. Zorn on new technologies to optimize care for BPH

Dr. Friel and Dr. Sterling on patient selection for Aquablation for BPH

Urologists share their initial experience with BPH treatment Aquablation

Dr. Sterling and Dr. Friel discuss Aquablation for BPH

Dr. Wymer on the implications of BPH procedure cost data

Investigators compare costs for surgical treatments of BPH

Dr. McVary discusses early promise with Rezum in large prostates

Study assesses Rezum therapy in large prostates

Dr. Zorn on prostatic artery embolization for BPH

Dr. Elterman on the new wave of BPH stents

CME Content

Medical Crossfire® in Adjunctive Testing: Charting a New Course in Prostate Cancer Risk Assessment

Working Together: Overcoming Barriers to Optimize Outcomes in Patients Treated With Radioligand Therapy Through Multidisciplinary Care

BURST CME™ Resource Center: Integrating Novel PSMA-Directed Radioligand Approaches for Diagnosis and Management of Prostate Cancer

Radioligand Therapy 101: The Science Behind the Strategy

Ready for Radioligand Therapy? Patient Selection and Sequencing Simplified

Community Practice Connections™: Beyond the Basics— Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies

Enhancing Prostate Cancer Outcomes – The Role of PSMA and Targeted Treatment Strategies

More News

Panel expert details changes to AUA BPH guideline

Photoselective vaporization of the prostate found safe, durably effective

PROs favor prostatic urethral lift over water vapor ablation for BPH symptoms

Trending on Urology Times

FDA approves capivasertib plus abiraterone and prednisone for PTEN-deficient mHSPC

Toni Choueiri, MD, reacts to FDA approval of adjuvant belzutifan with pembrolizumab for ccRCC

Dean Elterman, MD, highlights efficacy and safety data on the Zenflow Prostatic Spring

FDA approves adjuvant belzutifan with pembrolizumab for ccRCC

ACOU085 shows promise for cisplatin-induced hearing loss in patients with testicular cancer